Latest papers

The assessment of pathogenic prions in the brains of eye tissue donors: 2-years experience in the Czech Republic.

The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype.

A Yeast Toxic Mutant of HET-s(218-289) Prion Displays Alternative Intermediates of Amyloidogenesis

Characterization of atypical scrapie cases from Great Britain in transgenic ovine PrP mice.

The therapeutically anti-prion active antibody-fragment scFv-W226: paramagnetic relaxation-enhanced NMR spectroscopy aided structure elucidation of the paratope-epitope interface.

Cell-based quantification of chronic wasting disease prions.

Phase I/II safety study of transfusion of prion-filtered red cell concentrates in transfusion-dependent patients.

PrP-specific camel antibodies with the ability to immunodetect intracellular prion protein.

Accumulation of L-type bovine prions in peripheral nerve tissues.

Risk of escape of prions in gaseous emissions from on-farm digestion vessels.

Familial Creutzfeldt-Jakob disease with V180I mutation.

Cellular form of prion protein inhibits Reelin-mediated shedding of Caspr from the neuronal cell surface to potentiate Caspr-mediated inhibition of neurite outgrowth.

Sti1 regulation of Hsp70 and Hsp90 is critical for curing of Saccharomyces cerevisiae [PSI+] prions by Hsp104.

The mechanism of prion inhibition by HET-S.

Non-Mendelian determinant [ISP+] in yeast is a nuclear-residing prion form of the global transcriptional regulator Sfp1.

Conversion of a yeast prion protein to an infectious form in bacteria.

Natural polyphenols as inhibitors of amyloid aggregation. Molecular dynamics study of GNNQQNY heptapeptide decamer.

Enzymatic digestion of chronic wasting disease prions bound to soil.

Aerosol and nasal transmission of chronic wasting disease in cervidized mice.

In vivo detection of prion amyloid plaques using [(11)C]BF-227 PET.